BioCatalyst

LP352 — catalyst calendar

2 verified catalyst event(s) referencing LP352, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-21
in 2mo
ESTIMATED
 READOUT
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults
Phase 3 · Dravet Syndrome
 Longboard Pharmaceuticals LP352 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-10-31
in 4mo
ESTIMATED
 READOUT
A Study to Investigate LP352 in Children and Adults With Developmental and Epile
Phase 3 · Developmental and Epileptic Encephalopathy
 Longboard Pharmaceuticals LP352 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.